Cargando…
Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
BACKGROUND: Atypical antipsychotics as first-line drugs have been used in patients with schizophrenia in China and abroad. However, its safety still needs to be evaluated in a large population, especially in Chinese patients. OBJECTIVE: The main objective of this study is to evaluate the safety and...
Autores principales: | Yu, Wenjuan, Huang, Jingjing, He, Sidi, Zhang, Lei, Shen, Yifeng, Li, Huafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871676/ https://www.ncbi.nlm.nih.gov/pubmed/33644688 http://dx.doi.org/10.1136/gpsych-2020-100289 |
Ejemplares similares
-
Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022) -
Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study
por: Jiang, Yihe, et al.
Publicado: (2022) -
A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study
por: Li, Yange, et al.
Publicado: (2021) -
Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019) -
Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
por: Yu, Zhi-min, et al.
Publicado: (2019)